PolyPeptide Rg
PPGN
CHF
STOCK MARKET:
SWX
Closed
 
...
Large gap with delayed quotes
Last quote
09/03/2025 - 17:31:36
Bid
09/03/2025 - 17:49:57
Bid
Volume
Ask
09/03/2025 - 17:19:58
Ask
Volume
26.45
+0.35 ( +1.34% )
25.80
178
26.70
24
More information
Analysis by TheScreener
02.09.2025
Evaluation Neutral  
Interest Very strong  
Sensibility High  
Analysis date: 02.09.2025
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 08.08.2025.
Interest
  Very strong
Four stars since 29.08.2025.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 29.08.2025 at a price of 27.10.
Evaluation
  Undervalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 29.04.2025.
4wk Rel Perf
  13.85%
 
The four-week dividend-adjusted overperformance versus STOXX600 is 13.85%.
Sensibility
  High
High, no change over 1 year.
Bear Market Factor
  High
On average, the stock has a tendency to amplify the drops in the index by 0.96%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.90%.
Mkt Cap in $bn
  1.12
With a market capitalization <$2bn, POLYPEPTIDE GROUP AG is considered a small-cap stock.
G/PE Ratio
  3.87
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
  29.28
The estimated PE is for the year 2027.
LT Growth
  113.19%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  5
Over the last seven weeks, an average of 5 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  164
For 1% of index variation, the stock varies on average by 1.64%.
Correlation
  0.43
42.53% of stock movements are explained by index variations.
Value at Risk
  8.48
The value at risk is estimated at CHF 8.48. The risk is therefore 32.48%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  20.08.2021